DeepDR:用于药物反应预测的深度学习库.
Zhengxiang Jiang1,2, Pengyong Li1
1School of Computer Science and Technology, Xidian University, Xi'an, Shaanxi 710126, China.
Bioinformatics (Oxford, England)
|November 19, 2024
概括
DeepDR是一个新的深度学习库,简化了精准医学的药物反应预测. 它自动化了功能工程和模型构建,使先进的计算药物发现更容易获得.
科学领域:
- 计算生物学是一种计算生物学.
- 药物基因组学 药物基因组学
- 生物信息学是一种生物信息学.
背景情况:
- 准确的药物反应预测对于推进精准医学和药物发现至关重要.
- 深度学习 (DL) 在预测药物反应方面表现有前途,但缺乏实际工具.
- 现有的DL工具用于药物反应预测并不是用户友好或全面的.
研究的目的:
- 介绍DeepDR,这是第一个设计用于药物反应预测的深度学习库.
- 简化和自动化药物反应建模的过程.
- 为构建和评估各种DL模型提供灵活的平台.
主要方法:
- DeepDR自动化了药物和细胞特征化,模型构建,训练和推断.
- 该库支持三种药物特征类型和九种药物编码器.
- 它还包括四种细胞特征类型和九种细胞编码器,以及两个融合模块.
主要成果:
- 深度学习模型 (DeepDR) 可实现多达135种不同的深度学习模型.
- 使用DeepDR库对基准测试性能进行了探索.
- 通过基准测试确定的最佳模型可以通过视觉界面访问.
结论:
- DeepDR显著降低了将深度学习应用于药物反应预测的进入障碍.
- 该图书馆有助于开发更准确的准确医学预测模型.
- DeepDR支持研究人员加速药物发现和个性化治疗策略.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.2K
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
960
相关概念视频
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K
Drug-Receptor Bonds
2.7K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.7K
Drug-Receptor Interactions
5.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.0K
Dose-Response Relationship: Overview
3.0K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.0K
Analysis of Population Pharmacokinetic Data
235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235
